Number of nuclear medicine examinations unchanged, therapy volumes increasing

The Radiation and Nuclear Safety Authority (STUK) report "Nuclear medicine examinations and treatments in Finland in 2021", published in February 2023, presents the numbers of examinations, treatments and nuclear imaging equipment, and estimates the radiation exposure caused to adults by the examinations.
Inspector Iida Kuurne, the author of the report, says that the study examined the average radiation dose from nuclear medicine examinations carried out 2021 and the total combined radiation doses of Finns.
According to Iida Kuurne, the results show that only a small part of the radiation dose received by Finns is caused by nuclear medicine examinations. An adult participating in a single nuclear medicine examination receives an average dose of 3.4 millisieverts (mSv) from radiopharmaceuticals and a dose of 2.1 mSv from a CT scan, if this is done in addition to the nuclear medicine examination.
When the radiation exposure caused by nuclear medicine examinations is divided among all Finns, the radiation dose is less than 0.05 mSv per citizen per year. The dose has increased slightly in the last ten years. The increase is due to increased CT scans. The average radiation dose received by Finns from all sources combined is 5.9 millisieverts per year. More than five millisieverts come from natural radioactive materials, mainly radon.
The total number of nuclear medicine examinations has remained stable for the last 20 years. The most common nuclear medicine examinations were tumour imaging, examinations of skeletal and soft parts, and examinations of the circulatory system. The most widely used radioactive substances in imaging were technetium-99m, fluorine-18 and iodine-123.
The number of radionuclide therapies has increased every year in the last ten years. Compared to 2009, 58% more treatments were given in 2021. The most common radionuclide therapies are treatment of hyperthyroidism and cancer. The increase in the number of radionuclide therapies is due to new types of treatments that use, for example, Lutetium-177 for the treatment of prostate cancer. The most widely used radioactive substances in radionuclide therapies were iodine-131, lutetium-177 and radium-223.
In radionuclide therapies, as in other radiotherapies, radiation must be used sufficiently to obtain a therapeutic effect. It is international practice not to take radiation exposure into account when calculating the total exposure of citizens.
Keywords
Contacts
Inspector Iida Kuurne, tel. +358 9 759 88 2626
Senior Inspector Sampsa Kaijaluoto, tel. +358 9 759 88 2542
Media contacts, tel. +358 10 850 4761
Images

Links
About Säteilyturvakeskus (STUK)
Säteilyturvakeskus (STUK) on säteily- ja ydinturvallisuutta valvova viranomainen. Tehtävämme on ihmisten, yhteiskunnan, ympäristön ja tulevien sukupolvien suojelu säteilyn haitallisilta vaikutuksilta. STUKissa oli vuoden 2022 alussa yhteensä 336 työntekijää.
Strålsäkerhetscentralen (STUK) är en myndighet som övervakar strål- och kärnsäkerheten. Vårt uppdrag är att skydda människorna, samhället, miljön och de framtida generationerna för strålningens skadliga konsekvenser. I början av 2022 hade STUK sammanlagt 336 anställda.
Radiation and Nuclear Safety Authority (STUK) supervises radiation and nuclear safety in Finland. Our mission is to protect people, society, the environment and future generations from the detrimental effects of radiation. At the beginning of 2022 STUK had 336 employees.
Subscribe to releases from Säteilyturvakeskus (STUK)
Subscribe to all the latest releases from Säteilyturvakeskus (STUK) by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Säteilyturvakeskus (STUK)
Radioaktiva ämnen fortsätter att minska4.7.2025 09:57:23 EEST | Pressmeddelande
Strålsäkerhetscentralens årsrapport Strålningsövervakning av miljön i Finland berättar vilka radioaktiva ämnen som inte ursprungligen hörde till naturen som hittades år 2024, var de påträffades och i vilka mängder de förekommer i miljön.
Radioaktiivisten aineiden määrä yhä laskussa4.7.2025 09:57:23 EEST | Tiedote
Säteilyturvakeskuksen julkaisema Ympäristön säteilyvalvonta Suomessa -vuosiraportti kertoo, mitä luontoon alun perin kuulumattomia radioaktiivisia aineita vuonna 2024 löytyi, mistä niitä löytyi ja kuinka paljon niitä ympäristössä on.
Delta i forskningen – skicka in ditt svampprov till Strålsäkerhetscentralen23.6.2025 14:58:25 EEST | Pressmeddelande
Strålsäkerhetscentralen ordnar kampanjen Svamp 2025 som pågår från juli till slutet av november. Syftet med kampanjen är att utreda halterna av radioaktivt cesium (Cs-137) i matsvampsarter och skillnader i dessa halter i olika delar av landet och i olika svamparter. Under kampanjen kan du skicka prover på matsvamp från hela landet till Strålsäkerhetscentralen.
Tule mukaan tieteen tekemiseen - lähetä ruokasieninäyte Säteilyturvakeskukseen23.6.2025 14:58:25 EEST | Tiedote
Säteilyturvakeskus järjestää heinäkuusta marraskuun loppuun asti kestävän Sienet 2025 -kampanjan, jossa on tarkoitus selvittää ruokasienilajien radioaktiivisen cesiumin (Cs-137) pitoisuuksia ja pitoisuuseroja maan eri osissa ja eri sienilajeissa. Kampanjan aikana on mahdollista lähettää ruokasieninäytteitä ympäri maata Säteilyturvakeskukseen.
Take part in scientific research – Submit an edible mushroom sample to the Radiation and Nuclear Safety Authority23.6.2025 14:58:25 EEST | Press release
From July until the end of November, the Radiation and Nuclear Safety Authority will organise the Mushrooms 2025 campaign, the aim of which is to examine radioactive cesium (Cs-137) concentrations and differences in concentrations in edible mushroom species in different parts of the country and in different mushroom species. During the campaign, the public can send edible mushroom samples from all over the country to the Radiation and Nuclear Safety Authority.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom